Back to search

Management of Hepatic Sinusoidal Obstruction Syndrome Following Treatment with Gemtuzumab Ozogamicin (Mylotarg®)

Data up to Jan 2025

Published2002
Citations41
References25

Total Citations Per Year

Abstract

References (25)

Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury

2000 • 2,078 citations

Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients

1993 • 1,173 citations

Leucocyte typing IV : white cell differentiation antigens

1989 • 523 citations

Schiff's diseases of the liver

1999 • 441 citations

Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

2001 • 278 citations

Treatment of Severe Veno-Occlusive Disease With Defibrotide: Compassionate Use Results in Response Without Significant Toxicity in a High-Risk Population

1998 • 255 citations

Wedged and free hepatic venous pressure measured with a balloon catheter

1979 • 249 citations

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

2002 • 240 citations

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1998 • 205 citations

Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant Patients

1997 • 189 citations

Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study

2000 • 184 citations

Jaundice due to bacterial infection

1979 • 171 citations

UTILITY OF TRANSVENOUS LIVER BIOPSIES AND WEDGED HEPATIC VENOUS PRESSURE MEASUREMENTS IN SIXTY MARROW TRANSPLANT RECIPIENTS

1995 • 160 citations

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

2000 • 127 citations

Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation

2000 • 116 citations

N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation

2000 • 79 citations

Fungal Liver Infection in Marrow Transplant Recipients: Prevalence at Autopsy, Predisposing Factors, and Clinical Features

1995 • 75 citations

Clinicopathology conferences: Inflammation-induced cholestasis

1998 • 66 citations

Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings

2001 • 63 citations

Venocclusive disease of the liver: prospective study of US evaluation.

1992 • 56 citations

Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

2001 • 52 citations

Hepatic stellate cells (Ito cells) in veno‐occlusive disease of the liver after allogeneic bone marrow transplantation

1999 • 42 citations

Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver

1993 • 34 citations

Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease

2001 • 22 citations

APPLICATION OF NITRIC OXIDE FOR A CASE OF VENO-OCCLUSIVE DISEASE AFTER PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

2000 • 7 citations

Cited By (0)

Loading...
Management of Hepatic Sinusoidal Obstruction Syndrome Following Treatment with Gemtuzumab… (2002) – Clinical Lymphoma | Metascience Observatory Explorer